Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BML-210

HDAC inhibitor
 
BML-GR330-0001 1 mg 99.00 USD
 
BML-GR330-0005 5 mg 341.00 USD
Do you need bulk/larger quantities?
 
HDAC inhibitor developed at Enzo Life Sciences. Inhibits HDAC activity in HeLa nuclear extracts (IC50=5-10µM).

Product Details

Formula:C20H25N3O2
 
MW:339.4
 
CAS:537034-17-6
 
Purity:≥98% (TLC)
 
Appearance:Tan solid.
 
Solubility:Soluble in DMSO (25mg/ml) or 100% ethanol (10mg/ml, warm)
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Regulatory Status:RUO - Research Use Only
 
bml-gr330
Please mouse over
bml-gr330

Product Literature References

Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia: D. Herman, et al.; Nature Chem. Biol. 10, 551 (2006), Abstract;
The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines: J. Savickiene et al.; Eur J Pharmacol 549, 9 (2006), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
SDS
Certificate of Analysis

RELATED PRODUCTS

By target:
HDAC
By biological activity:
HDAC Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

Brochures
Epigenetics
Epigenetics
Download as PDF

All new literature pieces